31 March 2020 in BMC Health Services Research
Background: Intensive care units represent one of the largest clinical cost centers in hospitals. Mechanical ventilation accounts for a significant share of this cost. There is a relative dearth of information quantifying the impact of ventilation on daily ICU cost. We thus determine daily costs of ICU care, incremental cost of mechanical ventilation per ICU day, and further differentiate cost by underlying diseases. Methods: Total ICU costs, length of ICU stay, and duration of mechanical ventilation of all 10,637 adult patients treated in ICUs at a German hospital in 2013 were analyzed for never-ventilated patients (N = 9181), patients ventilated at least 1 day, (N = 1455) and all patients (N = 10,637). Total ICU costs were regressed on the number of ICU days. Finally, costs were analyzed separately by ICD-10 chapter of main diagnosis. Results: Daily non-ventilated costs were €999 (95%CI €924 - €1074), and ventilated costs were €1590 (95%CI €1524 - €1657), a 59% increase. Costs per non-ventilated ICU day differed substantially and were lowest for endocrine, nutritional or metabolic diseases (€844), and highest for musculoskeletal diseases (€1357). Costs per ventilated ICU day were lowest for diseases of the circulatory system (€1439) and highest for cancer patients (€1594). The relative cost increase due to ventilation was highest for diseases of the respiratory system (94%) and even non-systematic for patients with musculoskeletal diseases (13%, p = 0.634). Conclusions: Results show substantial variability of ICU costs for different underlying diseases and underline mechanical ventilation as an important driver of ICU costs.
7 October 2015 in BMC Psychiatry
Length of stay is a straightforward measure of hospital costs and retrospective data are widely available. However, a prospective idea of a patient’s length of stay would be required to predetermine hospital reimbursement per case based on patient classifications. The aim of this study was to analyse the predictive power of patient characteristics in terms of length of stay in a psychiatric hospital setting. A further aim was to use patient characteristics to predict episodes with extreme length of stay. The study included all inpatient episodes admitted in 2013 to a psychiatric hospital. Zero-truncated negative binomial regression was carried out to predict length of stay. Penalized maximum likelihood logistic regressions were carried out to predict episodes experiencing extreme length of stay. Independent variables were chosen on the basis of prior research and model fit was cross-validated. A total of 738 inpatient episodes were included. Seven patient characteristics showed significant effects on length of stay. The strongest increasing effects were found in the presence of affective disorders as main diagnosis, followed by severity of disease and chronicity of disease. The strongest decreasing effects were found in danger to others, followed by the presence of substance-related disorders as main diagnosis, the daily requirement of somatic care and male gender. The squared correlation between out-of-sample predictions and observed values was 0.14. The root-mean-square-error was 40 days. Prospectively defining reimbursement per case might not be feasible in mental health because length of stay cannot be predicted by patient characteristics. Per diem systems should be used.
19 June 2021 in Pharmacoepidemiology and Drug Safety
Purpose: The aim of this study was to analyze the epidemiology of polypharmacy in hospital psychiatry. Another aim was to investigate predictors of the number of drugs taken and the associated risks of drug–drug interactions and potentially inappropriate medications in the elderly.Methods: Daily prescription data were obtained from a pharmacovigilance project sponsored by the Innovations Funds of the German Federal Joint Committee.Results: The study included 47 071 inpatient hospital cases from eight different study centers. The mean number of different drugs during the entire stay was 6.1 (psychotropic drugs = 2.7; others = 3.4). The mean number of drugs per day was 3.8 (psychotropic drugs = 1.6; others = 2.2). One third of cases received at least five different drugs per day on average during their hospital stay (polypharmacy). Fifty‐one percent of patients received more than one psychotropic drug simultaneously. Hospital cases with polypharmacy were 18 years older (p < 0.001), more likely to be female (52% vs. 40%,p < 0.001) and had more comorbidities (5 vs. 2,p < 0.001) than hospital cases without polypharmacy. The risks of drug–drug interactions (OR = 3.7; 95% CI = 3.5–3.9) and potentially inappropriate medication use in the elderly (OR = 2.2; CI = 1.9–2.5) substantially increased in patients that received polypharmacy.Conclusion: Polypharmacy is frequent in clinical care. The number of used drugs is a proven risk factor of adverse drug reactions due to drug–drug interactions and potentially inappropriate medication use in the elderly. The potential interactions and the specific pharmacokinetics and ‐dynamics of older patients should always be considered when multiple drugs are used.
13 March 2015 in Social Psychiatry and Psychiatric Epidemiology
30 January 2018 in BMC Health Services Research
Psychiatric comorbidities are relevant for the diagnostic and therapeutic regimes in somatic hospital care. The main aim of this study was to analyse the association between psychiatric comorbidities and hospital costs per inpatient episode. A further aim was to discuss and address the methodological challenges in the estimation of these outcomes based on retrospective data. The study included 338,162 inpatient episodes consecutively discharged between 2011 and 2014 at a German university hospital. We used detailed resource use data to calculate day-specific hospital costs. We adjusted analyses for sex, age, somatic comorbidities and main diagnoses. We addressed potential time-related bias in retrospective diagnosis data with sensitivity analyses. Psychiatric comorbidities were associated with an increase in hospital costs per episode of 40% and an increase of reimbursement per episode of 28%, representing marginal effects of 1344 € and 1004 €, respectively. After controlling for length of stay, sensitivity analyses provided a lower bound increase in daily costs and reimbursement of 207 € and 151 €, respectively. If differences in hospital costs between patient groups are not adequately accounted for in DRG-systems, perverse incentives are created that can reduce the efficiency of care. Therefore, we suggest intensifying the inclusion of psychiatric comorbidities in the German DRG system. Future research should investigate the appropriate inclusion of psychiatric comorbidities in other health care systems’ payment schemes.